Post-approval studies (Phase 4)Study completedNCT01514708What this trial is testingThe Safety and Immune Response to Influenza Vaccination in Pregnant WomenWho this might be right forInfluenza Adimmune Corporation 46
Not applicableStudy completedNCT05493787What this trial is testingNudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu ShotWho this might be right forInfluenza Geisinger Clinic 139,503
Testing effectiveness (Phase 2)Active Not RecruitingNCT07291635What this trial is testingPhase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza VaccineWho this might be right forInfluenza Aramis Biotechnologies Inc. 728
Large-scale testing (Phase 3)Study completedNCT01854632What this trial is testingClinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in SenegalWho this might be right forInfluenza PATH 1,761
Post-approval studies (Phase 4)Study completedNCT01499914What this trial is testingCohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza VaccinationWho this might be right forCystic Fibrosis With Gastrointestinal Manifestation Assistance Publique - Hôpitaux de Paris 439
Post-approval studies (Phase 4)Study completedNCT01190215What this trial is testingImmunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTMWho this might be right forInfluenza GlaxoSmithKline 77
Not applicableStudy completedNCT04402684What this trial is testingInfluenza Vaccination in Patients Living With HIV in the Northern RegionWho this might be right forHIV Tourcoing Hospital 124
Post-approval studies (Phase 4)Study completedNCT01863849What this trial is testingTolerability and Immunogenicity Study of Fluval AB Suspension for InjectionWho this might be right forInfluenza Prophylaxis Fluart Innovative Vaccine Ltd, Hungary 120
Testing effectiveness (Phase 2)Study completedNCT01879540What this trial is testingSafety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of AgeWho this might be right forHuman Influenza Novartis Vaccines 63
Not applicableLooking for participantsNCT05334615What this trial is testingCOVID-19 Coagulopathy Extension StudyWho this might be right forCOVID-19 University of Iowa 180
Large-scale testing (Phase 3)Study completedNCT02572817What this trial is testingComparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza AWho this might be right forInfluenza A Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 138
Early research (Phase 1)Study completedNCT07737106What this trial is testingPhase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)Who this might be right forInfluenza Sinovac Biotech Co., Ltd 50
Large-scale testing (Phase 3)Study completedNCT00949533What this trial is testingA Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal InfluenzaWho this might be right forInfluenza Hoffmann-La Roche 37
Not applicableStudy completedNCT02198638What this trial is testingEffect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays UnitsWho this might be right forPatient With Influenza Like Illness Hospices Civils de Lyon 541
Very early researchStudy completedNCT04484532What this trial is testingEvaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy VolunteersWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome Roswell Park Cancer Institute 130
Testing effectiveness (Phase 2)Study completedNCT01195038What this trial is testingImmunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed AdultsWho this might be right forInfluenza UMN Pharma Inc. 87
Not applicableLooking for participantsNCT06620185What this trial is testingGEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuEWho this might be right forInfluenza Imperial College London 36
Early research (Phase 1)Study completedNCT00457509What this trial is testingSafety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy AdultsWho this might be right forPandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections Sanofi Pasteur, a Sanofi Company 251
Not applicableStudy completedNCT01431326What this trial is testingPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareWho this might be right forAdenovirusAnesthesiaAnxiety+56 more Daniel Benjamin 3,520
Testing effectiveness (Phase 2)Study completedNCT02469298What this trial is testingSafety, Tolerability and Clinical Effect of Danirixin in Adults With InfluenzaWho this might be right forVirus Diseases GlaxoSmithKline 45